Novo Nordisk announced they're partnering with telehealth companies like Hims & Hers, Ro, and LifeMD to make Wegovy more accessible now that the shortage is ending.
Hims & Hers stock jumped 23% on the news, and Novo Nordisk's went up 4%.
The idea is to get more people on the official drug now...